-
ABOUT USThe company is a professional API manufacturer established and developed by Shijiazhuang No.4 Pharmaceutical Group to actively promote the development strategy of "API + preparation"
-
INNOVATIONDevelops fine, series, high-end API and innovative API intermediates with high added value through overcoming key technologies such as API synthesis to build variety competition advantages.
-
PRODUCTSWith the annual production 500MT of hydroxyethyl starch , 500MT of azithromycin , we are ranking in the API professional enterprises in Hebei Province and even in China .
-
RECRUITGuolong has jointly established engineering laboratories, technology research centers and other high-level innovation platforms with CAS, Zhejiang University, Tianjin University and other universities
-
CONTACTAdhering to the "love the people with quality, formed the base with integrity" business philosophy, is committed to developing the domestic high-end market and the international market.
2023-02-10
Guangxiang Pharmaceutical Group was awarded the title of “Occupational Health Enterprise” for 2022 by Hebei Province.
Recently, six departments—the Hebei Provincial Health Commission, the Provincial Department of Industry and Information Technology, the Provincial Department of Ecology and Environment, the Provincial Federation of Trade Unions, the Communist Youth League Hebei Provincial Committee, and the Provincial Women’s Federation—jointly released the list of “Occupational Health Enterprises” for Hebei Province in 2022. Hebei Guangxiang Pharmaceutical Co., Ltd., part of our group, was successfully included on the list and awarded the title of “Occupational Health Enterprise” by the province.
2023-01-07
Shijiazhuang Sihua Pharmaceutical Group’s Guangxiang Pharmaceutical has been recognized as a provincial demonstration enterprise for technological innovation.
On January 6, the Hebei Provincial Department of Industry and Information Technology released the list of provincial-level demonstration enterprises for technological innovation for 2022. Among them, 36 companies—including Hebei Guangxiang Pharmaceutical Co., Ltd.—were recognized by the Provincial Department of Industry and Information Technology as provincial-level demonstration enterprises for technological innovation in 2022.
2022-12-31
Two products from Shijiazhuang Sihua Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have been recognized as provincial manufacturing single-champion products.
Recently, the Hebei Provincial Department of Industry and Information Technology released the fourth list of provincial manufacturing single-champion enterprises and single-champion products. Both Metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Siyao Group, and Hydroxyethyl Starch produced by Hebei Guolong Pharmaceutical Co., Ltd. have been recognized as Hebei Province’s manufacturing single-champion products.
Recently, the active pharmaceutical ingredient—aggrastat—submitted by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Fourth Pharmaceutical Group, has been approved by the National Medical Products Administration for registration as an API intended for use in marketed formulations.
07
2022/09
Recently, the Department of Industry and Information Technology of Hebei Province announced the list of key cultivation projects for innovative development of the provincial industrial internet in 2022. The high-end intelligent manufacturing upgrade project for active pharmaceutical ingredients (APIs) of Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Siyao Group, was included on the list of key cultivation projects.
29
2022/07
On June 23, the active pharmaceutical ingredient—rosuvastatin calcium—submitted by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Four Pharmaceutical Group, was approved by the National Medical Products Administration and has been registered as an active pharmaceutical ingredient for use in marketed formulations.
23
2022/06
Recently, three active pharmaceutical ingredients—pentoxifylline, levonidazole, and ornidazole—submitted by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Fourth Pharmaceutical Group, have been approved by the National Medical Products Administration and can now be officially used in marketed formulations.
27
2022/05
Shijiazhuang Fourth Pharmaceutical Group has once again received good news from its research and development efforts. Recently, the active pharmaceutical ingredient—lacosamide—developed and submitted by the group’s Hebei Guangxiang Pharmaceutical Co., Ltd. has been approved by the National Medical Products Administration and can now be officially used in marketed formulations.
17
2022/05
Recently, the active pharmaceutical ingredient—pitavastatin calcium—developed and submitted by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Four Pharmaceutical Group, has been approved by the National Medical Products Administration and can now be officially used in marketed formulations.
14
2022/05
On March 18, two Class 4 chemical drugs developed by Shijiazhuang Sihua Pharmaceutical Co., Ltd.—moxifloxacin hydrochloride eye drops and levofloxacin sodium injection—obtained “Drug Registration Certificates” issued by the National Medical Products Administration (NMPA) and are deemed to have passed the evaluation of consistency in quality and efficacy for generic drugs. In addition, the active pharmaceutical ingredient epalrestat, submitted by Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Group, has also been approved by the NMPA and can now be used in marketed formulations.
19
2022/03
Recently, the Department of Industry and Information Technology of Hebei Province announced the fourth batch of “Specialized, Fine, Distinctive, and Innovative” demonstration enterprises in Hebei Province. Shijiazhuang Sihua Pharmaceutical Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd. were both recognized as Hebei Province’s “Specialized, Fine, Distinctive, and Innovative” demonstration enterprises.
22
2022/01
Recently, the Hebei Provincial Department of Science and Technology announced the ninth list of “Innovative Talents for Technology-Based SMEs.” Among those honored are four employees from Hebei Guangxiang Pharmaceutical Co., Ltd., a subsidiary of Shijiazhuang Sihua Pharmaceutical Group: Cui Yongbin, Cui Xinhua, Zhang Weijin, and Ma Hui.
20
2022/01
On December 8, the Department of Industry and Information Technology of Hebei Province released a notice announcing the list of quality benchmarks for industrial enterprises in the province for 2021. After recommendations from municipal bureaus across Hebei Province, expert reviews, and public announcements, “The Experience of Implementing Quality and Safety Management Throughout the Entire Lifecycle of Pharmaceuticals” by Shijiazhuang Sihua Pharmaceutical Co., Ltd. and “The Experience of Using Micro-Reaction Continuous Synthesis Technology to Control Residual Solvent Quality in Drug Manufacturing” by the Group’s Hebei Guangxiang Pharmaceutical Co., Ltd. were designated as the 2021 quality benchmarks for industrial enterprises in Hebei Province.
20
2022/01
SERVICE HOTLINE
Zip Code: 052165
Address: No.9 Xingye Street, Gaocheng District, Shijiazhuang City, Hebei Province
Mobile site
E code
Business license